Which pharmaceutical company rebranded its revolutionary artificial insulin product from 'Humulin' to a more consumer-friendly name with an injection pen system that revolutionized diabetes management in the 1990s?

The healthcare and pharmaceutical industry invests billions in branding and product design to build recognition and trust. Behind many successful medical products are fascinating brand stories that reflect changes in medical science, market positioning, and consumer needs. This trivia question explores how a major pharmaceutical company rebranded a breakthrough product to maximize its market acceptance and patient adoption.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Eli Lilly with 'Humalog'
• Pfizer with 'Insulease'
• Novo Nordisk with 'NovoRapid'
• GlaxoSmithKline with 'GlucoEase'

Powered by AIPolls.Net — AI-powered real-time polling platform.